Pharmaplex SRL
Pharmaplex reported total assets of 482,967 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).
The score of Pharmaplex shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +96 % Total assets -5 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmaplex's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 23,269 € | ||||
| Equity | 204,100 € | ||||
| Cash | 154,235 € | ||||
| EBITDA | 35,363 € | ||||
| Total assets | 482,967 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 27 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 30 Aug 2022
Pharmaplex's financial analysis
- Solvency42.3%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmaplex
Pharmaplex's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0479.578.292
- VAT number
- BE0479578292
- Peppol
- Registered · 0208:0479578292 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Feb 2003
- Registered office
- 1970 Wezembeek-Oppem
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
Pharmaplex (SRL) has been based in Wezembeek-Oppem since 2003, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports a net profit of 23,269 € and equity of 204,100 €; its revenue is not published. Its solvency stands at 42.3%, below the median of its sector (60.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharmaplex
Companies in the same business, of comparable size and area, outside its group.
- Susty Wastes Solutions Research and experimental development on natural sciences and engineering Blegny · balance sheet 548,782 €
- "Clinical & Quality Support" Research and experimental development on natural sciences and engineering Villers-la-Ville · balance sheet 67,856 €
- KST R & D Research and experimental development on natural sciences and engineering Liège · balance sheet 65,816 €
- MethodX Research and experimental development on natural sciences and engineering Waterloo · balance sheet 509,257 €
- IuMeDa Research and experimental development on natural sciences and engineering Leuven · balance sheet 66,280 €
- Soetemont Consulting Research and experimental development on natural sciences and engineering Uccle · balance sheet 628,120 €
- Medcot Research and experimental development on natural sciences and engineering Waterloo · balance sheet 542,923 €
- Cabinet Grumbers Research and experimental development on natural sciences and engineering Lessines · balance sheet 642,094 €
Frequently asked questions about Pharmaplex
What is the revenue of Pharmaplex?
Pharmaplex files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmaplex?
In Belgium, the VAT number is the company number prefixed with BE: BE0479578292 for Pharmaplex, if the company is VAT-registered. Its company number (CBE) is 0479.578.292.
Where is the registered office of Pharmaplex?
According to the CBE register, the registered office of Pharmaplex is in 1970 Wezembeek-Oppem.
What is the equity of Pharmaplex?
At the close of the 2025 financial year, the equity of Pharmaplex amounts to 204,100 €, a solvency of 42.3% of total assets.
Who manages Pharmaplex?
The register lists 3 active mandates at Pharmaplex. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmaplex
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →